Imugene Commences Patient Dosing in Phase 1 Bile Tract Cancer Trial; Shares Up 8%
Imugene Commences Patient Dosing in Phase 1 Bile Tract Cancer Trial; Shares Up 8%
Imugene公司已開始第1期膽管癌臨床試驗的患者用藥；股價上漲8％。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊